FDA commissioner to drug middlemen: You're part of the problem
April 19, 2018 at 15:30 PM EDT
Drug manufacturers are using several schemes to "hamstring biosimilar competition," and FDA Commissioner Scott Gottlieb worries pharmacy benefit managers have been "complacent participants" in them.